Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (141-150 of 229) with videos related to

Pageof 23
Sort By:
Scientific Reports|January 18, 2018
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency AblationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|March 6, 2009
Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systemsTeh-Ia Huo, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Journal of Hepatology|September 15, 2009
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinomaJaw-Ching Wu, Yi-Hsiang Huang, Gar-Yang Chau, et al.
Journal of the Chinese Medical Association : JCMA|April 6, 2013
Validation of the behavior and concept based assessment of professionalism competence in postgraduate first-year residentsYing-Ying Yang, Fa-Yauh Lee, Hui-Chi Hsu, et al.
Journal of Gastroenterology and Hepatology|March 23, 2012
Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategyChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Journal of Gastroenterology and Hepatology|June 23, 2021
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Plos One|June 7, 2014
A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systemsYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
European Journal of Gastroenterology & Hepatology|May 4, 2011
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio indexWei-Yu Kao, Yi-You Chiou, Hung-Hsu Hung, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failureChia-Yang Hsu, Fa-Yauh Lee, Teh-Ia Huo, et al.
Journal of the Chinese Medical Association : JCMA|May 21, 2020
Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemicChun-Fan Chen, Yung-Tai Chen, Tz-Heng Chen, et al.
Pageof 23

Showing results (141-150 of 229) with videos related to

Sort By:
Pageof 23
Scientific Reports|January 18, 2018
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency AblationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|March 6, 2009
Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systemsTeh-Ia Huo, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Journal of Hepatology|September 15, 2009
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinomaJaw-Ching Wu, Yi-Hsiang Huang, Gar-Yang Chau, et al.
Journal of the Chinese Medical Association : JCMA|April 6, 2013
Validation of the behavior and concept based assessment of professionalism competence in postgraduate first-year residentsYing-Ying Yang, Fa-Yauh Lee, Hui-Chi Hsu, et al.
Journal of Gastroenterology and Hepatology|March 23, 2012
Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategyChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Journal of Gastroenterology and Hepatology|June 23, 2021
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Plos One|June 7, 2014
A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systemsYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
European Journal of Gastroenterology & Hepatology|May 4, 2011
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio indexWei-Yu Kao, Yi-You Chiou, Hung-Hsu Hung, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failureChia-Yang Hsu, Fa-Yauh Lee, Teh-Ia Huo, et al.
Journal of the Chinese Medical Association : JCMA|May 21, 2020
Judicious use of sodium-glucose cotransporter 2 inhibitors in patients with diabetes on coronavirus-19 pandemicChun-Fan Chen, Yung-Tai Chen, Tz-Heng Chen, et al.
Pageof 23